Back
MaxCyte Vs. Neurogene Industry Stock Comparison
Sell
17
MXCT
MaxCyte
Last Price:
3.42
Seasonality Move:
-8.13%
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Sell
17
MaxCyte (MXCT)
is a Sell
Is MaxCyte a Buy, Sell or Hold?
- The current MaxCyte [MXCT] share price is $3.42. The Score for MXCT is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
- MXCT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
MXCT Stock Price Chart
MXCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 39.64 | Sell |
Chaikin Money Flow: | -261880 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (3.51 - 3.83) | Sell |
Bollinger Bands (100): | (3.67 - 4.39) | Sell |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 35.74 | Sell |
Chaikin Money Flow: | -452975 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.4 - 61.5) | Sell |
Bollinger Bands (100): | (34.32 - 50.52) | Sell |
MXCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.53 | Sell |
20-day SMA: | 3.64 | Sell |
50-day SMA: | 3.78 | Sell |
200-day SMA: | 4.21 | Sell |
8-day EMA: | 3.52 | Sell |
20-day EMA: | 3.62 | Sell |
50-day EMA: | 3.78 | Sell |
200-day EMA: | 4.12 | Sell |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.3 | Sell |
20-day SMA: | 51.47 | Sell |
50-day SMA: | 46.76 | Sell |
200-day SMA: | 38.99 | Sell |
8-day EMA: | 47.13 | Sell |
20-day EMA: | 50.2 | Sell |
50-day EMA: | 47.47 | Sell |
200-day EMA: | 38.44 | Sell |
MaxCyte Earnings Growth & MXCT Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.02 per share, and an increase next year of $0.02 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
MaxCyte Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |